Press Release

Merck Millipore Adds Protein PEGylation to Portfolio of Services for Biopharmaceutical Industry through Collaboration with celares GmbH

Merck Millipore, the Life Science business of Merck, and celares GmbH today announced a collaboration with celares GmbH to provide PEGylation services to customers developing protein-based therapeutics and biosimilars.

The new service offering enabled by the collaboration includes feasibility studies, process and analytical development, and scale-up from milligram to gram quantities required for pilot and subsequent commercial scale.